Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)
NCT07513506
This study is recruiting at 11 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a research study to compare an investigational infant formula against a currently marketed infant formula. An investigational infant formula is one that has never been approved by the United States Food and Drug Administration (FDA). The purpose of this research study is to evaluate the growth and tolerance of infants who consume a new (not yet available to buy) extensively hydrolyzed cow milk protein infant formula compared to an extensively hydrolyzed cow milk protein infant formula that is currently available to buy.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Growth
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 10 to 14 days
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Mead Johnson Nutrition
- Last updated on ClinicalTrials.gov
- October 20, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 2
- Alabama Clinical Therapeutics · Birmingham, AL
- Alabama Clinical Therapeutics · Birmingham, AL
Arkansas · 1
- Childrens Clinic of Jonesboro · Jonesboro, AR
Florida · 2
- SPRIM · Harbor Beach, FL
- Symphony Research · Jacksonville, FL
Illinois · 1
- Mid Valley Research Inc. · Moline, IL
Kentucky · 1
- Springs Medical Research · Owensboro, KY
North Carolina · 1
- InnovoResearch · Wilmington, NC
Tennessee · 1
- AVIATI Healthcare & Clinical Research · Memphis, TN
Texas · 1
- NeutraLife Science · Richmond, TX
Utah · 1
- AMR · Syracuse, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.